| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.414 | 0.006 | 0.414 | Anesthetic local | 0.386 0.007 CID_54736 0.284 0.014 CID_55647 | ||
| 0.414 | 0.072 | 0.468 | Calcium channel L-type activator | 0.467 0.042 CID_54736 0.468 0.041 CID_55647 | CID_55647 | |
| 0.336 | 0.014 | 0.336 | 5 Hydroxytryptamine 1E antagonist | 0.322 0.018 CID_54736 0.289 0.037 CID_55647 | ||
| 0.242 | 0.008 | 0.242 | 5 Hydroxytryptamine 1F antagonist | 0.218 0.009 CID_54736 0.097 0.033 CID_55647 | ||
| 0.359 | 0.138 | 0.361 | Caspase 9 stimulant | 0.331 0.162 CID_54736 0.361 0.137 CID_55647 | CID_55647 | |
| 0.255 | 0.048 | 0.255 | Sigma receptor agonist | 0.227 0.054 CID_54736 0.132 0.1 CID_55647 | ||
| 0.269 | 0.074 | 0.269 | Ca(v)3.3 blocker | 0.228 0.137 CID_54736 0.237 0.121 CID_55647 | ||
| 0.198 | 0.007 | 0.198 | 5 Hydroxytryptamine 1D antagonist | 0.113 0.018 CID_54736 0.098 0.023 CID_55647 | ||
| 0.203 | 0.029 | 0.224 | Catenin beta inhibitor | 0.224 0.018 CID_54736 0.162 0.079 CID_55647 | CID_54736 | |
| 0.176 | 0.011 | 0.176 | Acetylcholine nicotinic agonist | 0.17 0.012 CID_54736 0.175 0.011 CID_55647 | ||
| 0.175 | 0.015 | 0.175 | Acetylcholine nicotinic antagonist | 0.165 0.017 CID_54736 0.145 0.022 CID_55647 | ||
| 0.165 | 0.019 | 0.165 | Sphingomyelinase inhibitor | 0.117 0.044 CID_54736 0.148 0.025 CID_55647 | ||
| 0.241 | 0.095 | 0.281 | Spasmolytic | 0.281 0.078 CID_54736 0.169 0.146 CID_55647 | CID_54736 | |
| 0.152 | 0.008 | 0.152 | Nicotinic alpha4beta2 receptor antagonist | 0.143 0.009 CID_54736 0.143 0.009 CID_55647 | ||
| 0.176 | 0.034 | 0.176 | Nav1.3 sodium channel blocker | 0.138 0.057 CID_54736 0.119 0.075 CID_55647 | ||
| 0.148 | 0.006 | 0.148 | Nicotinic receptor alpha7 subunit antagonist | 0.13 0.008 CID_54736 0.1 0.012 CID_55647 | ||
| 0.164 | 0.03 | 0.164 | Falcipain 3 inhibitor | 0.144 0.039 CID_54736 0.117 0.056 CID_55647 | ||
| 0.183 | 0.05 | 0.232 | Acetylcholine M1 receptor antagonist | 0.232 0.03 CID_54736 0.125 0.102 CID_55647 | CID_54736 | |
| 0.184 | 0.053 | 0.196 | ATPase inhibitor | 0.196 0.04 CID_54736 | CID_54736 | |
| 0.196 | 0.066 | 0.196 | P-glycoprotein inhibitor | 0.172 0.088 CID_54736 0.177 0.082 CID_55647 | ||
| 0.141 | 0.013 | 0.141 | Neuronal nicotinic receptor antagonist | 0.131 0.015 CID_54736 0.115 0.019 CID_55647 | ||
| 0.152 | 0.025 | 0.152 | Acetylcholine agonist | 0.113 0.039 CID_54736 0.108 0.042 CID_55647 | ||
| 0.221 | 0.102 | 0.315 | Tyrosine 3 hydroxylase inhibitor | 0.315 0.027 CID_54736 0.232 0.088 CID_55647 | CID_54736 | |
| 0.143 | 0.026 | 0.176 | Nitric-oxide synthase inhibitor | 0.137 0.028 CID_54736 0.176 0.014 CID_55647 | CID_55647 | |
| 0.163 | 0.05 | 0.163 | Nav1.2 sodium channel blocker | 0.136 0.067 CID_54736 0.125 0.078 CID_55647 | ||
| 0.157 | 0.046 | 0.19 | Acetylcholine antagonist | 0.19 0.033 CID_54736 0.112 0.078 CID_55647 | CID_54736 | |
| 0.159 | 0.048 | 0.192 | Cholinergic antagonist | 0.192 0.034 CID_54736 0.113 0.081 CID_55647 | CID_54736 | |
| 0.253 | 0.156 | 0.253 | Beta lactamase inhibitor | |||
| 0.226 | 0.129 | 0.233 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.233 0.122 CID_54736 0.188 0.171 CID_55647 | CID_54736 | |
| 0.135 | 0.038 | 0.135 | Nav1.5 sodium channel blocker | 0.105 0.075 CID_54736 | ||
| 0.218 | 0.122 | 0.22 | Gastrin inhibitor | 0.22 0.118 CID_54736 0.191 0.162 CID_55647 | CID_54736 | |
| 0.13 | 0.035 | 0.13 | Acetylcholine release stimulant | |||
| 0.12 | 0.03 | 0.12 | Polo-like kinase-1 inhibitor | 0.093 0.056 CID_54736 0.09 0.061 CID_55647 | ||
| 0.148 | 0.061 | 0.159 | Neurotrophic factor | 0.159 0.051 CID_54736 0.121 0.093 CID_55647 | CID_54736 | |
| 0.097 | 0.013 | 0.097 | Orexin receptor antagonist | 0.069 0.041 CID_55647 | ||
| 0.156 | 0.072 | 0.156 | Cholinergic | 0.123 0.104 CID_54736 | ||
| 0.133 | 0.052 | 0.133 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.239 | 0.157 | 0.247 | Calpain 2 inhibitor | 0.21 0.179 CID_54736 0.247 0.151 CID_55647 | CID_55647 | |
| 0.095 | 0.017 | 0.095 | Orexin receptor 1 antagonist | 0.074 0.044 CID_55647 | ||
| 0.09 | 0.017 | 0.09 | Potassium channel (Tandem pore domain) blocker | 0.079 0.037 CID_54736 0.076 0.044 CID_55647 | ||
| 0.179 | 0.108 | 0.179 | Potassium channel blocker | |||
| 0.083 | 0.012 | 0.083 | Nicotinic receptor alpha4 subunit antagonist | 0.083 0.012 CID_54736 0.054 0.027 CID_55647 | ||
| 0.085 | 0.018 | 0.085 | Nicotinic neuronal receptor agonist | 0.065 0.031 CID_54736 0.066 0.031 CID_55647 | ||
| 0.1 | 0.037 | 0.186 | Inducible nitric-oxide synthase inhibitor | 0.095 0.042 CID_54736 0.186 0.01 CID_55647 | CID_55647 | |
| 0.267 | 0.205 | 0.366 | 5 Hydroxytryptamine release inhibitor | 0.298 0.167 CID_54736 0.366 0.102 CID_55647 | CID_55647 | |
| 0.108 | 0.046 | 0.108 | Glutamate (mGluR7) agonist | 0.105 0.05 CID_55647 | ||
| 0.289 | 0.228 | 0.318 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.284 0.235 CID_54736 0.318 0.189 CID_55647 | CID_55647 | |
| 0.109 | 0.048 | 0.133 | Breast cancer-resistant protein inhibitor | 0.133 0.032 CID_55647 | CID_55647 | |
| 0.089 | 0.029 | 0.089 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.062 | 0.005 | 0.077 | Carnitine palmitoyltransferase inhibitor | 0.04 0.016 CID_54736 0.077 0.004 CID_55647 | CID_55647 | |
| 0.061 | 0.005 | 0.078 | Carnitine palmitoyltransferase 1 inhibitor | 0.04 0.015 CID_54736 0.078 0.004 CID_55647 | CID_55647 | |
| 0.162 | 0.106 | 0.173 | Psychostimulant | 0.173 0.098 CID_54736 | CID_54736 | |
| 0.152 | 0.099 | 0.163 | Amyloid beta precursor protein antagonist | 0.163 0.088 CID_54736 | CID_54736 | |
| 0.1 | 0.049 | 0.114 | Bile acid receptor antagonist | 0.114 0.025 CID_54736 0.098 0.054 CID_55647 | CID_54736 | |
| 0.2 | 0.151 | 0.217 | 5 Hydroxytryptamine uptake stimulant | 0.217 0.122 CID_54736 0.215 0.125 CID_55647 | CID_54736 | |
| 0.115 | 0.067 | 0.115 | 5 Hydroxytryptamine antagonist | |||
| 0.07 | 0.023 | 0.07 | Nicotinic alpha7 receptor agonist | 0.049 0.044 CID_54736 | ||
| 0.119 | 0.074 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.117 0.077 CID_54736 0.152 0.032 CID_55647 | CID_55647 | |
| 0.104 | 0.061 | 0.115 | Nav1.1 sodium channel blocker | 0.115 0.052 CID_54736 | CID_54736 | |
| 0.057 | 0.013 | 0.063 | Nicotinic receptor beta4 subunit antagonist | 0.063 0.011 CID_54736 | CID_54736 | |
| 0.102 | 0.06 | 0.103 | Hedgehog signaling inhibitor | 0.103 0.059 CID_54736 0.098 0.068 CID_55647 | CID_54736 | |
| 0.084 | 0.044 | 0.084 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.069 | 0.031 | 0.069 | Dopamine uptake inhibitor | 0.063 0.035 CID_54736 0.056 0.043 CID_55647 | ||
| 0.236 | 0.201 | 0.236 | DNA polymerase beta inhibitor | |||
| 0.258 | 0.224 | 0.258 | MAP kinase 1 inhibitor | |||
| 0.062 | 0.029 | 0.09 | Sphingosine kinase 2 inhibitor | 0.09 0.011 CID_54736 0.066 0.025 CID_55647 | CID_54736 | |
| 0.11 | 0.078 | 0.139 | Acetylcholine muscarinic antagonist | 0.139 0.051 CID_54736 | CID_54736 | |
| 0.186 | 0.155 | 0.195 | Transcription factor STAT3 inhibitor | 0.195 0.14 CID_54736 | CID_54736 | |
| 0.053 | 0.023 | 0.055 | Nicotinic receptor alpha3 subunit antagonist | 0.055 0.022 CID_54736 | CID_54736 | |
| 0.084 | 0.056 | 0.084 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.121 | 0.094 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.063 CID_54736 0.123 0.089 CID_55647 | CID_54736 | |
| 0.055 | 0.028 | 0.055 | Potassium channel (Inward rectifier) blocker | |||
| 0.083 | 0.059 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.052 | 0.03 | 0.052 | Dopamine transporter inhibitor | 0.049 0.033 CID_54736 0.045 0.037 CID_55647 | ||
| 0.127 | 0.106 | 0.151 | Neuropeptide Y1 antagonist | 0.126 0.109 CID_54736 0.151 0.064 CID_55647 | CID_55647 | |
| 0.047 | 0.026 | 0.047 | CC chemokine 3 receptor antagonist | 0.042 0.029 CID_55647 | ||
| 0.05 | 0.029 | 0.05 | Factor Xa inhibitor | |||
| 0.063 | 0.043 | 0.071 | Acetylcholine M2 receptor antagonist | 0.071 0.036 CID_54736 | CID_54736 | |
| 0.045 | 0.025 | 0.071 | Histone deacetylase 8 inhibitor | 0.045 0.026 CID_54736 0.071 0.012 CID_55647 | CID_55647 | |
| 0.071 | 0.052 | 0.071 | Polo-like kinase-2 inhibitor | 0.07 0.053 CID_54736 | ||
| 0.09 | 0.072 | 0.09 | Alpha 2d adrenoreceptor antagonist | 0.086 0.081 CID_54736 | ||
| 0.039 | 0.022 | 0.039 | Orexin receptor 2 antagonist | |||
| 0.08 | 0.064 | 0.08 | T cell inhibitor | 0.079 0.07 CID_54736 | ||
| 0.03 | 0.013 | 0.03 | 5 Hydroxytryptamine 1F agonist | 0.03 0.013 CID_54736 | ||
| 0.113 | 0.097 | 0.113 | Cytokine production inhibitor | |||
| 0.031 | 0.016 | 0.031 | Carnitine palmitoyltransferase 1A inhibitor | 0.029 0.019 CID_55647 | ||
| 0.09 | 0.075 | 0.09 | Alpha 2c adrenoreceptor antagonist | |||
| 0.057 | 0.044 | 0.1 | Sphingosine kinase inhibitor | 0.087 0.012 CID_54736 0.1 0.008 CID_55647 | CID_55647 | |
| 0.067 | 0.057 | 0.067 | Dopamine antagonist | |||
| 0.051 | 0.042 | 0.051 | Acetylcholine muscarinic agonist | |||
| 0.179 | 0.17 | 0.212 | Transcription factor STAT inhibitor | 0.212 0.122 CID_54736 | CID_54736 | |
| 0.051 | 0.042 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.045 CID_54736 | ||
| 0.028 | 0.021 | 0.028 | 5 Hydroxytryptamine 1D agonist | |||
| 0.192 | 0.187 | 0.238 | Antithrombotic | 0.238 0.136 CID_54736 | CID_54736 | |
| 0.044 | 0.04 | 0.045 | Carnitine palmitoyltransferase 1B inhibitor | 0.045 0.039 CID_55647 | CID_55647 | |
| 0.082 | 0.08 | 0.082 | Butyrylcholinesterase inhibitor | |||
| 0.094 | 0.091 | 0.094 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.13 | 0.129 | 0.132 | DNA methyltransferase I inhibitor | 0.132 0.126 CID_54736 | CID_54736 | |
| 0.102 | 0.101 | 0.139 | Transcription factor STAT6 inhibitor | 0.139 0.034 CID_54736 | CID_54736 | |
| 0.216 | 0.218 | 0.293 | Analgesic | 0.293 0.147 CID_54736 | CID_54736 | |
| 0.116 | 0.118 | 0.142 | Anticoagulant | 0.131 0.099 CID_54736 0.142 0.088 CID_55647 | CID_55647 | |
| 0.131 | 0.135 | 0.163 | Anesthetic general | 0.163 0.1 CID_54736 | CID_54736 | |
| 0.119 | 0.123 | 0.153 | Growth hormone agonist | 0.153 0.085 CID_54736 | CID_54736 | |
| 0.136 | 0.142 | 0.159 | Neurotensin receptor agonist | 0.159 0.081 CID_54736 0.148 0.107 CID_55647 | CID_54736 | |
| 0.073 | 0.08 | 0.12 | Opioid antagonist | 0.12 0.036 CID_54736 | CID_54736 | |
| 0.043 | 0.051 | 0.049 | Protein kinase C epsilon inhibitor | 0.049 0.042 CID_54736 | CID_54736 | |
| 0.16 | 0.169 | 0.216 | Peptidyltransferase inhibitor | 0.216 0.081 CID_54736 | CID_54736 | |
| 0.044 | 0.054 | 0.071 | Plasminogen activator inhibitor | 0.057 0.042 CID_54736 0.071 0.031 CID_55647 | CID_55647 | |
| 0.015 | 0.026 | 0.022 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_55647 | CID_55647 | |
| 0.057 | 0.068 | 0.063 | Prolactin release inhibitor | 0.063 0.039 CID_54736 | CID_54736 | |
| 0.063 | 0.074 | 0.095 | Analgesic, opioid | 0.095 0.034 CID_54736 | CID_54736 | |
| 0.169 | 0.185 | 0.2 | Neuropeptide Y2 antagonist | 0.2 0.12 CID_54736 0.176 0.169 CID_55647 | CID_54736 | |
| 0.066 | 0.085 | 0.098 | Opioid kappa receptor antagonist | 0.098 0.037 CID_54736 | CID_54736 | |
| 0.156 | 0.178 | 0.248 | Superoxide dismutase inhibitor | 0.174 0.15 CID_54736 0.248 0.076 CID_55647 | CID_55647 | |
| 0.019 | 0.045 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.025 CID_55647 | CID_55647 | |
| 0.042 | 0.068 | 0.048 | Factor III inhibitor | 0.048 0.041 CID_55647 | CID_55647 | |
| 0.031 | 0.061 | 0.056 | Sphingosine kinase 1 inhibitor | 0.045 0.022 CID_54736 0.056 0.012 CID_55647 | CID_55647 | |
| 0.025 | 0.056 | 0.042 | Histone deacetylase class I inhibitor | 0.042 0.025 CID_55647 | CID_55647 | |
| 0.011 | 0.043 | 0.021 | Complement factor D inhibitor | 0.021 0.008 CID_55647 | CID_55647 | |
| 0.038 | 0.07 | 0.058 | CXC chemokine 1 receptor antagonist | 0.058 0.024 CID_54736 | CID_54736 | |
| 0.112 | 0.146 | 0.122 | Death-associated protein kinase 1 inhibitor | 0.122 0.105 CID_55647 | CID_55647 | |
| 0.156 | 0.192 | 0.204 | Nitric-oxide synthase stimulant | 0.172 0.147 CID_54736 0.204 0.082 CID_55647 | CID_55647 | |
| 0.081 | 0.117 | 0.104 | Protein kinase C gamma inhibitor | 0.104 0.07 CID_54736 | CID_54736 | |
| 0.112 | 0.15 | 0.132 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.096 CID_54736 0.132 0.096 CID_55647 | CID_55647 | |
| 0.042 | 0.08 | 0.091 | Opioid mu receptor antagonist | 0.091 0.035 CID_54736 | CID_54736 | |
| 0.075 | 0.114 | 0.102 | 5 Hydroxytryptamine 3A agonist | 0.102 0.073 CID_54736 | CID_54736 | |
| 0.066 | 0.105 | 0.089 | Protease inhibitor | 0.089 0.075 CID_55647 | CID_55647 | |
| 0.038 | 0.078 | 0.062 | Acetylcholine M3 receptor antagonist | 0.062 0.039 CID_54736 | CID_54736 | |
| 0.166 | 0.207 | 0.226 | Transcription factor NF kappa B inhibitor | 0.226 0.145 CID_54736 | CID_54736 | |
| 0.169 | 0.211 | 0.269 | Insulysin inhibitor | 0.241 0.105 CID_54736 0.269 0.08 CID_55647 | CID_55647 | |
| 0.029 | 0.071 | 0.046 | Opioid mu receptor agonist | 0.046 0.033 CID_54736 | CID_54736 | |
| 0.024 | 0.067 | 0.038 | Opioid kappa receptor agonist | 0.038 0.037 CID_54736 | CID_54736 | |
| 0.05 | 0.094 | 0.067 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 CID_54736 0.067 0.033 CID_55647 | CID_55647 | |
| 0.114 | 0.158 | 0.163 | Tumour necrosis factor antagonist | 0.163 0.084 CID_55647 | CID_55647 | |
| 0.142 | 0.188 | 0.153 | MAP kinase kinase 5 inhibitor | 0.153 0.141 CID_55647 | CID_55647 | |
| 0.064 | 0.112 | 0.077 | Factor XII inhibitor | 0.077 0.073 CID_55647 | CID_55647 | |
| 0.041 | 0.089 | 0.056 | Dopamine D1 antagonist | 0.056 0.055 CID_54736 | CID_54736 | |
| 0.037 | 0.085 | 0.082 | NMDA 2C receptor antagonist | 0.082 0.024 CID_54736 | CID_54736 | |
| 0.132 | 0.183 | 0.191 | Interleukin agonist | 0.191 0.129 CID_54736 0.172 0.147 CID_55647 | CID_54736 | |
| 0.01 | 0.062 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.013 CID_55647 | CID_55647 | |
| 0.026 | 0.079 | 0.046 | Melanocortin antagonist | 0.046 0.034 CID_55647 | CID_55647 | |
| 0.021 | 0.079 | 0.052 | Oxytocin agonist | 0.052 0.023 CID_54736 | CID_54736 | |
| 0.061 | 0.122 | 0.111 | Prolactin inhibitor | 0.111 0.045 CID_54736 | CID_54736 | |
| 0.018 | 0.08 | 0.037 | Melanocortin 4 antagonist | 0.037 0.035 CID_55647 | CID_55647 | |
| 0.026 | 0.089 | 0.07 | Dihydroorotase inhibitor | 0.07 0.011 CID_55647 | CID_55647 | |
| 0.12 | 0.185 | 0.13 | Heat shock protein 70 antagonist | 0.13 0.123 CID_54736 | CID_54736 | |
| 0.04 | 0.106 | 0.062 | Histone deacetylase inhibitor | 0.062 0.05 CID_55647 | CID_55647 | |
| 0.028 | 0.096 | 0.068 | Opioid delta receptor antagonist | 0.068 0.041 CID_54736 | CID_54736 | |
| 0.042 | 0.112 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.061 0.04 CID_54736 | CID_54736 | |
| 0.023 | 0.095 | 0.047 | Opioid agonist | 0.047 0.044 CID_54736 | CID_54736 | |
| 0.099 | 0.173 | 0.122 | Hemostatic | 0.12 0.115 CID_54736 0.122 0.11 CID_55647 | CID_55647 | |
| 0.131 | 0.206 | 0.163 | Calpain inhibitor | 0.163 0.158 CID_55647 | CID_55647 | |
| 0.04 | 0.116 | 0.074 | Protein kinase C beta inhibitor | 0.074 0.039 CID_54736 | CID_54736 | |
| 0.167 | 0.254 | 0.247 | Interleukin 2 agonist | 0.247 0.122 CID_54736 | CID_54736 | |
| 0.064 | 0.16 | 0.089 | CC chemokine 5 receptor agonist | 0.089 0.039 CID_54736 | CID_54736 | |
| 0.158 | 0.255 | 0.192 | Apoptosis antagonist | 0.192 0.19 CID_54736 | CID_54736 | |
| 0.089 | 0.189 | 0.122 | Farnesoid X receptor antagonist | 0.122 0.1 CID_54736 | CID_54736 | |
| 0.013 | 0.114 | 0.069 | Somatostatin agonist | 0.069 0.01 CID_55647 | CID_55647 | |
| 0.128 | 0.229 | 0.166 | 5 Hydroxytryptamine release stimulant | 0.166 0.159 CID_55647 | CID_55647 | |
| 0.159 | 0.266 | 0.227 | Histamine release inhibitor | 0.227 0.174 CID_54736 | CID_54736 | |
| 0.056 | 0.163 | 0.087 | MAP kinase kinase 7 inhibitor | 0.087 0.029 CID_54736 | CID_54736 | |
| 0.092 | 0.205 | 0.112 | Papain-like protease (SARS coronavirus) inhibitor | 0.112 0.106 CID_54736 | CID_54736 | |
| 0.066 | 0.197 | 0.103 | Toll-Like receptor 2 antagonist | 0.103 0.1 CID_55647 | CID_55647 | |
| 0.01 | 0.141 | 0.042 | Gonadotropin-releasing hormone receptor antagonist | 0.042 0.019 CID_55647 | CID_55647 | |
| 0.094 | 0.228 | 0.129 | CF transmembrane conductance regulator agonist | 0.129 0.12 CID_55647 | CID_55647 | |
| 0.005 | 0.141 | 0.033 | Somatostatin 2 agonist | 0.033 0.005 CID_55647 | CID_55647 | |
| 0.142 | 0.281 | 0.212 | 15-Lipoxygenase inhibitor | 0.212 0.2 CID_54736 | CID_54736 | |
| 0.018 | 0.167 | 0.083 | NMDA 2 receptor antagonist | 0.083 0.042 CID_54736 | CID_54736 | |
| 0.055 | 0.206 | 0.122 | Bone formation stimulant | 0.122 0.084 CID_55647 | CID_55647 | |
| 0.036 | 0.205 | 0.111 | Check point kinase 2 inhibitor | 0.111 0.056 CID_55647 | CID_55647 | |
| 0.015 | 0.264 | 0.064 | Phenylethanolamine N methyltransferase inhibitor | 0.064 0.006 CID_55647 | CID_55647 | |
| 0.026 | 0.406 | 0.092 | Estrogen receptor beta antagonist | 0.092 0.08 CID_54736 | CID_54736 | |
| 0.034 | 0.416 | 0.103 | Estrogen antagonist | 0.103 0.092 CID_54736 | CID_54736 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |